Regulation of B- and T-cell mediated xenogeneic transplant rejection by interleukin 12

Transplantation

Volumn 81, Issue 2, 2006, Pages 265-272

  Hosiawa, Karoline A ^a,b   Wang, Hao ^b   DeVries, Mark E ^a   Garcia, Bertha ^b   Jiang, Jifu ^b   Zhou, Dejun ^a   Cameron, Mark J ^a,f   Zhong, Robert ^b,c,d,e   Kelvin, David J ^a,f,g  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^e ROBARTS RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Antibodies; B cells; Cytokines; T cells; Transplantation

Indexed keywords

CD34 ANTIGEN; CYTOKINE; FAS LIGAND; INTERLEUKIN 12; INTERLEUKIN 12P40; ISOENZYME; MESSENGER RNA; SERINE PROTEINASE; COMPLEMENTARY DNA; HETEROPHILE ANTIBODY; PROTEIN SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD VESSEL GRAFT; CARDIAC GRAFT REJECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; XENOGRAFT; XENOTRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; GENETICS; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEWIS RAT; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ANIMALS; ANTIBODIES, HETEROPHILE; B-LYMPHOCYTES; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; DNA, COMPLEMENTARY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN SUBUNITS; RATS; RATS, INBRED LEW; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644850827     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000196725.53277.60     Document Type: Article

References (35)

1. Logan JS. Prospects for xenotransplantation. Curr Opin Immunol 2000; 12: 563-568.
2. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
3. Auchincloss H, Jr., Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433-470.
4. Platt JL. New directions for organ transplantation. Nature 1998; 392: 11-17.
5. Cooper DK, Gollackner B, Knosalla C, Teranishi K. Xenotransplantation - how far have we come? Transpl Immunol 2002; 9: 251-256.
6. Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, et al. The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000; 70: 1667-1674.
7. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745-1756.
8. Platt JL, Nagayasu T. Current status of xenotransplantation. Clin Exp Pharmacol Physiol 1999; 26: 1026-1032.
9. Rothstein DM, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 2003; 196: 85-108.
10. DiSesa VJ. Cardiac xenotransplantation. Ann Thorac Surg 1997; 64: 1858-1865.
11. Moses RD, Pierson RN, III, Winn HJ, Auchincloss H, Jr. Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567-575.
12. Wang H, DeVries ME, Deng S, et al. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nat Med 2000; 6: 549-555.
13. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003; 14: 361-368.
14. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
15. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-725.
16. Lee BO, Haynes L, Eaton SM, et al. The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J Exp Med 2002; 196: 693-704.
17. Murphy EE, Terres G, Macatonia SE, et al. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med 1994; 180: 223-231.
18. Ma X. TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 2001; 3: 121-129.
19. Gately MK, Warrier RR, Honasoge S, et al. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int Immunol 1994; 6: 157-167.
20. Piccotti JR, Li K, Chan SY, et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol 1998; 160: 1132-1138.
21. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343-350.
22. Schuurman HJ, Cheng J, Lam T. Pathology of xenograft rejection: a commentary. Xenotransplantation 2003; 10: 293-299.
23. Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437-446.
24. Snanoudj R, Beaudreuil S, Arzouk N, et al. Immunological strategies targeting B cells in organ grafting. Transplantation 2005; 79: S33-S36.
25. Durali D, de Goer de Herve MG, Giron-Michel J, et al. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 2003; 102: 4084-4089.
26. Naldini A, Aarden L, Pucci A, et al. Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses. Br J Pharmacol 2003; 140: 980-986.
27. Le Moine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation 2002; 73: 1373-1381.
28. Singh NP, Guo L, Que X, Shirwan H. Blockade of indirect recognition mediated by CD4+ T cells leads to prolonged cardiac xenograft survival. Xenotransplantation 2004; 11: 33-42.
29. Koulmanda M, Laufer TM, Auchincloss H, Jr., Smith RN. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response. Xenotransplantation 2004; 11: 525-530.
30. Matsumiya G, Shirakura R, Miyagawa S, et al. Role of CD4+ T cells in the rat to mouse cardiac xenotransplantation. Transpl Int 1994; 7 Suppl 1: S654-S659.
31. Brouard S, Vanhove B, Gagne K, et al. T cell repertoire alterations of vascularized xenografts. J Immunol 1999; 162: 3367-3377.
32. Smyth MJ, Kershaw MH, Trapani JA. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo. Transplantation 1997; 63: 1171-1178.
33. Chua AO, Chizzonite R, Desai BB, et al. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 1994; 153: 128-136.
34. Kreisel D, Krupnick AS, Balsara KR, et al. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol 2002; 169: 6154-6161.
35. Kano M, Bashuda H, Yagita H, et al. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice. Transplantation 1998; 65: 837-843.